Nordicus Partners

Nordicus Partners (OTCQB: NORD) expanded its Board of Directors from three to five members. Henrik Keller resigned, and Torben Jensen, Kim T. Mücke, and Andrew J. Ritter were appointed. These appointments align with Nordicus’s strategy to acquire majority stakes in Nordic and U.S. life sciences companies. The new directors bring expertise in funding, accounting, and strategic relationships, supporting Nordicus’s goal to bridge Nordic innovation with the U.S. market.